Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Mylan to Acquire, Create Women's Health Care Franchise

February 2, 2015 10:19 am | by Mylan | News | Comments

Mylan Inc. announced that it has, through its Indian subsidiary Mylan Laboratories Limited, signed a definitive agreement to acquire certain female health care businesses from Famy Care Limited, a specialty women's health care company with global leadership in generic oral contraceptive products (OCPs) for $750 million in cash plus additional contingent payments of up to $50 million. Read more..


Theravance Biopharma, Mylan to Develop COPD Compound

February 2, 2015 10:14 am | by Theravance Biopharma | News | Comments

Theravance Biopharma, Inc. and Mylan Inc. announced that the two companies will partner on the development and, subject to FDA approval, commercialization of TD-4208, a novel investigational once-daily nebulized long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD) and other respiratory diseases. Read more...


EMD Millipore, Precision Biologics to Advance Monoclonal Antibody

February 2, 2015 10:09 am | by EMD Millipore | News | Comments

EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, announced an agreement for providing upstream process development services for Precision Biologics, Inc., a Texas-based clinical-stage biotechnology company, to advance a preclinical monoclonal antibody. Read more...


AbbVie: Top-line Results from Phase 3 Hepatitis C Treatment

February 2, 2015 10:04 am | by AbbVie | News | Comments

AbbVie released top-line Phase 3 results for its investigational, all-oral, ribavirin (RBV)-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir (OBV/PTV/r) in patients with genotype 1b (GT1b) chronic hepatitis C virus (HCV) infection in Japan. Read more...


President Obama Reveals Details About Precision Medicine Project

February 1, 2015 6:56 pm | by Ryan Bushey, Associate Editor | Articles | Comments

President Obama held a press conference revealing new details surrounding the Precision Medicine initiative he announced during the State of The Union. Read more...               


White House: Science Indicates Parents Should Vaccinate Kids

January 30, 2015 4:29 pm | by Nedra Pickler - Associated Press | News | Comments

Amid the measles outbreak stemming from California, the White House is telling parents that science indicates they should vaccinate their children. Read more...                 


Insurers May Be Using Drug Costs to Discriminate

January 30, 2015 4:22 pm | by Kelli Kennedy - Associated Press | News | Comments

One of the cornerstones of President Obama's signature health law forbids insurance companies from turning away people with pre-existing conditions such as diabetes or cancer. Read more...            


FDA Approves Janssen's B-Cell Lymphoma Treatment

January 30, 2015 11:11 am | News | Comments

This is the first therapy indicated specifically for patients with Waldenström’s macroglobulinemia. Read more...                         


Obama Proposes 'Precision Medicine' to End One-Size-Fits-All

January 30, 2015 10:48 am | by Lauran Neergard - AP Medical Writer | News | Comments

President Barack Obama is calling for an investment to move away from one-size-fits-all-medicine, toward an approach that tailors treatment to your genes. Read more...                


Some Doctors Won't See Patients with Anti-Vaccine Views

January 30, 2015 10:42 am | by Alicia Chang - AP Science Writer | News | Comments

The tough-love approach - which comes amid the nation's second-biggest measles outbreak in at least 15 years, with at least 98 cases reported since last month - raises questions about doctors' ethical responsibilities. Read more...     


AbbVie Reports Better-Than-Expected 4Q on Humira Sales

January 30, 2015 10:36 am | by Associated Press | News | Comments

Drugmaker Abbvie posted better-than-expected adjusted results for the fourth quarter on Friday due to double-digit growth of its blockbuster anti-inflammatory drug Humira. Read more...             


Study Shows Tamiflu Gets Patients Back on Their Feet Faster

January 30, 2015 10:30 am | by University of Michigan | News | Comments

New evidence about a popular antiviral—often criticized as ineffective—shows that it can alleviate symptoms and prevent respiratory complications. Read more...                 


Study Reveals More Dangers of Smoking While Pregnant

January 30, 2015 9:37 am | by University of Aberdeen | News | Comments

Smoking while pregnant causes chemical changes to the DNA of a foetus detectable from as early as 12 weeks and may predispose children born to smokers to a range of health conditions which last throughout life. Read more...      


Astellas, Immunomic Therapeutics Announce Licensing Agreement for Allergy Vaccine

January 30, 2015 9:32 am | News | Comments

The vaccine is designed to treat allergies induced by Japanese red cedar pollen. Read more...                            


Hot on the Trail of the Hepatitis-Liver Cancer Connection

January 30, 2015 9:26 am | by Riken Institute | News | Comments

Scientists have for the first time demonstrated the profound effect that chronic hepatitis infection and inflammation can have on the genetic mutations found in tumors of the liver. Read more...           



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.